112.69
price up icon1.93%   2.13
 
loading

Gilead Sciences Inc (GILD) 最新ニュース

pulisher
Oct 03, 2025

Gilead Sciences (GILD) Laps the Stock Market: Here's Why - sharewise.com

Oct 03, 2025
pulisher
Oct 03, 2025

RBC Capital Maintains a Hold Rating on Gilead Sciences (GILD) - Insider Monkey

Oct 03, 2025
pulisher
Oct 03, 2025

Gilead Foundation Commits Over $6.5M in New Grant Funding to Support STEM Education Pathways - Yahoo Finance

Oct 03, 2025
pulisher
Oct 03, 2025

How Gilead Sciences Inc. (Common Stock) (GIS0) stock responds to bond marketMarket Sentiment Summary & High Conviction Buy Zone Picks - newser.com

Oct 03, 2025
pulisher
Oct 02, 2025

Will Gilead Sciences Inc. (Common Stock) (GIS0) stock recover faster than industry2025 Year in Review & Stock Portfolio Risk Control - newser.com

Oct 02, 2025
pulisher
Oct 02, 2025

Gilead Sciences, Inc. (GILD) Is a Trending Stock: Facts to Know Before Betting on It - Yahoo

Oct 02, 2025
pulisher
Oct 02, 2025

Gilead’s Lost Decade Is Over. It’s Time to Buy the Stock. - Barron's

Oct 02, 2025
pulisher
Oct 01, 2025

Gilead stock faces potential hit if Biktarvy is Trump’s price cut target - Investing.com

Oct 01, 2025
pulisher
Oct 01, 2025

Potential Price Pressures for Gilead (GILD) Shares - GuruFocus

Oct 01, 2025
pulisher
Oct 01, 2025

RBC on Gilead Sciences (GILD): 'Could Biktarvy Be The $137 Pill Trump Wants To Cut To $18' - StreetInsider

Oct 01, 2025
pulisher
Oct 01, 2025

Marginal Zone Lymphoma Market Growth Projections 2024-2034: DelveInsight Analysis | Gilead Sciences, AstraZeneca, Nordic Nanovector, Christian Buske, AbbVie, Pharmacyclics LLC, Hutchison Medipharma - The Globe and Mail

Oct 01, 2025
pulisher
Oct 01, 2025

Immatics Appoints Venkat Ramanan as Chief Financial Officer - GlobeNewswire Inc.

Oct 01, 2025
pulisher
Oct 01, 2025

Using flow based indicators on Gilead Sciences Inc.2025 Sector Review & Short-Term High Return Strategies - newser.com

Oct 01, 2025
pulisher
Sep 30, 2025

Gilead Sciences Surges 26.5% YTD: Buy, Sell or Hold the Stock? - MSN

Sep 30, 2025
pulisher
Sep 30, 2025

Insider Sell: Daniel O'Day Sells 10,000 Shares of Gilead Sciences Inc (GILD) - GuruFocus

Sep 30, 2025
pulisher
Sep 30, 2025

How to integrate Gilead Sciences Inc. into portfolio analysis toolsEarnings Miss & Weekly High Conviction Trade Ideas - newser.com

Sep 30, 2025
pulisher
Sep 30, 2025

What Do Analysts Think About Gilead Sciences (GILD)? - Insider Monkey

Sep 30, 2025
pulisher
Sep 30, 2025

Gilead signs $34.5M deal for Hanmi/HHP’s I.V.-to-oral drug tech - BioWorld MedTech

Sep 30, 2025
pulisher
Sep 30, 2025

Gilead Sciences Begins On New California Manufacturing Hub - Construction Equipment Guide

Sep 30, 2025
pulisher
Sep 30, 2025

One Wealth Advisors LLC Has $1.02 Million Stock Holdings in Gilead Sciences, Inc. $GILD - MarketBeat

Sep 30, 2025
pulisher
Sep 30, 2025

Earnings visualization tools for Gilead Sciences Inc.2025 Risk Factors & Expert Approved Trade Ideas - newser.com

Sep 30, 2025
pulisher
Sep 30, 2025

Capital Investment Advisors LLC Boosts Stake in Gilead Sciences, Inc. $GILD - MarketBeat

Sep 30, 2025
pulisher
Sep 30, 2025

Raleigh Capital Management Inc. Sells 6,315 Shares of Gilead Sciences, Inc. $GILD - MarketBeat

Sep 30, 2025
pulisher
Sep 30, 2025

GC Wealth Management RIA LLC Boosts Stake in Gilead Sciences, Inc. $GILD - MarketBeat

Sep 30, 2025
pulisher
Sep 30, 2025

Avior Wealth Management LLC Boosts Stock Position in Gilead Sciences, Inc. $GILD - MarketBeat

Sep 30, 2025
pulisher
Sep 30, 2025

Hong Kong's Health Hope Pharma enters into virology deal with Gilead Sciences - BioSpectrum Asia

Sep 30, 2025
pulisher
Sep 29, 2025

Will Gilead Sciences Inc. stock keep outperforming rivals2025 Top Decliners & Safe Capital Growth Trade Ideas - newser.com

Sep 29, 2025
pulisher
Sep 29, 2025

Gilead pumps up virology pipeline with drug transporter deal - Fierce Biotech

Sep 29, 2025
pulisher
Sep 29, 2025

What analyst consensus implies for Gilead Sciences Inc. (GIS) stockSell Signal & Smart Allocation Stock Tips - newser.com

Sep 29, 2025
pulisher
Sep 29, 2025

Health Hope Pharma Enters into Exclusive Licensing Agreement with Gilead Sciences - PR Newswire UK

Sep 29, 2025
pulisher
Sep 29, 2025

Hanmi, HHP license oral drug delivery compound to Gilead By Investing.com - Investing.com Canada

Sep 29, 2025
pulisher
Sep 29, 2025

Hanmi Pharmaceutical Signs Global Licensing Agreement with Gilead Sciences and Health Hope Pharma for Encequidar - Korea IT Times

Sep 29, 2025
pulisher
Sep 29, 2025

Hanmi's Oral Delivery Platform Compound Licensed to Gilead - Eastern Progress

Sep 29, 2025
pulisher
Sep 29, 2025

Real time scanner hits for Gilead Sciences Inc. explainedQuarterly Portfolio Summary & Reliable Intraday Trade Plans - newser.com

Sep 29, 2025
pulisher
Sep 29, 2025

Hanmi's oral delivery platform compound licensed to Gilead - MarketScreener

Sep 29, 2025
pulisher
Sep 29, 2025

Hanmi Pharm licenses oral drug delivery compound to Gilead Sciences - StreetInsider

Sep 29, 2025
pulisher
Sep 29, 2025

Short interest data insights for Gilead Sciences Inc.2025 Investor Takeaways & Weekly Momentum Picks - newser.com

Sep 29, 2025
pulisher
Sep 29, 2025

Gilead Sciences, Inc. $GILD Shares Sold by First County Bank CT - MarketBeat

Sep 29, 2025
pulisher
Sep 29, 2025

Hanmi sells Encequidar oral absorption tech to Gilead in up to $34.5M dealCHOSUNBIZ - Chosun Biz

Sep 29, 2025
pulisher
Sep 29, 2025

Will Gilead Sciences Inc. stock deliver strong dividend growth2025 Top Decliners & Weekly Return Optimization Plans - newser.com

Sep 29, 2025
pulisher
Sep 29, 2025

Morgan Stanley Maintains Buy on Gilead Sciences (GILD) - Insider Monkey

Sep 29, 2025
pulisher
Sep 29, 2025

Why Gilead Sciences Inc. (GIS) stock is a must watch tickerMarket Movement Recap & Free Weekly Watchlist of Top Performers - newser.com

Sep 29, 2025
pulisher
Sep 28, 2025

Gilead Sciences, Inc. (NASDAQ:GILD) Is Favoured by Institutional Owners Who Hold 88% of the Company - 富途牛牛

Sep 28, 2025
pulisher
Sep 28, 2025

Old Port Advisors Buys Shares of 7,321 Gilead Sciences, Inc. $GILD - MarketBeat

Sep 28, 2025
pulisher
Sep 27, 2025

What analysts say about Gilead Sciences Inc GIS stockREITs Market Trends & Free Risk Assessment and Control - Early Times

Sep 27, 2025
pulisher
Sep 27, 2025

Kathmere Capital Management LLC Boosts Stock Position in Gilead Sciences, Inc. $GILD - MarketBeat

Sep 27, 2025
pulisher
Sep 27, 2025

State of Alaska Department of Revenue Sells 6,285 Shares of Gilead Sciences, Inc. $GILD - MarketBeat

Sep 27, 2025
pulisher
Sep 27, 2025

Gilead Sciences (GILD) Stock Sees Positive Outlook Amid HIV, Liver, and Cancer Drug Momentum - Yahoo Finance

Sep 27, 2025
pulisher
Sep 26, 2025

How Gilead Sciences Inc. (Common Stock) (GIS0) stock moves in volatile trading sessions2025 Valuation Update & Safe Capital Growth Stock Tips - newser.com

Sep 26, 2025
pulisher
Sep 26, 2025

Is Gilead Sciences Inc. (GIS) stock included in top ETFsBuy Signal & Stock Portfolio Risk Management - newser.com

Sep 26, 2025
pulisher
Sep 26, 2025

JPMorgan Lifts Gilead Sciences, Inc. (GILD)’s Price Target To $145, Maintains Overweight Rating - MSN

Sep 26, 2025
pulisher
Sep 26, 2025

Banque Pictet & Cie SA Grows Stock Holdings in Gilead Sciences, Inc. $GILD - MarketBeat

Sep 26, 2025
pulisher
Sep 26, 2025

Gilead Sciences, Inc. $GILD Shares Sold by Meyer Handelman Co. - MarketBeat

Sep 26, 2025
pulisher
Sep 26, 2025

Perigon Wealth Management LLC Has $4.02 Million Holdings in Gilead Sciences, Inc. $GILD - MarketBeat

Sep 26, 2025
pulisher
Sep 26, 2025

Understanding Gilead Sciences Inc.’s price movementWeekly Volume Report & AI Driven Price Forecasts - newser.com

Sep 26, 2025
drug_manufacturers_general SNY
$50.90
price up icon 1.52%
drug_manufacturers_general PFE
$27.37
price up icon 1.07%
$297.89
price up icon 0.16%
drug_manufacturers_general NVO
$59.63
price up icon 1.52%
drug_manufacturers_general MRK
$89.19
price down icon 0.36%
大文字化:     |  ボリューム (24 時間):